Inventor · disambiguated record
W. Fraser Symmans
Also filed as: SYMMANS W F · SYMMANS W FRASER
2 granted patents·7 pending applications·7 citations·filing 2002–2015
51Inventor score
Files withNUVERA BIOSCIENCES INC3MILLENNIUM PHARM INC2UNIV TEXAS2HATZIS CHRISTOS1MILLENIUM PHARMACEUTICALS INC1
Top patents by PatentIndex Score
9 records- 0163US7504222B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Mar 17, 2009·6 cites·15 claims
- 0258US7711494B2Method of measuring residual cancer and predicting patient survivalUNIV TEXAS·Filed 2007·Granted May 4, 2010·1 cites·14 claims
- 0353US2010009358A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 0447US2010311601A1Index of genomic expression of estrogen receptor (er) and er-related genesNUVERA BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 0546US2007134688A1Calculated index of genomic expression of estrogen receptor (er) and er-related genesNUVERA BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 0645US2015376710A1Methods of evaluating response to cancer therapyUNIV TEXAS·Filed 2015·Application pending·0 cites
- 0741US2013084570A1Methods of evaluating response to cancer therapyHATZIS CHRISTOS·Filed 2011·Application pending·0 cites
- 0841US2015368721A1Index of genomic expression of estrogen receptor (er) and er-related genesNUVERA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 0940US2005266420A1Multigene predictors of response to chemotherapyMILLENIUM PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when W. Fraser Symmans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →